Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.

Hirono, Seiichiro; Hasegawa, Yuzo; Sakaida, Tsukasa; Uchino, Yoshio; Hatano, Kazuo; Iuchi, Toshihiko

Hirono, Seiichiro; Hasegawa, Yuzo; Sakaida, Tsukasa; Uchino, Yoshio; Hatano, Kazuo; Iuchi, Toshihiko.

Affiliation

Hirono S; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba, 260-8717, Japan. s-hirono@umin.ac.jp.
Hasegawa Y; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba, 260-8717, Japan.
Sakaida T; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba, 260-8717, Japan.
Uchino Y; Division of Nuclear Medicine Chiba Ryogo Center, 3-30-1 Isobe, Mihama-ku, Chiba, 261-0012, Japan.
Hatano K; Division of Radiation Oncology, Tokyo Bay Advanced Imaging and Radiation Oncology Clinic, 1-17 Toyosuna, Mihama-ku, Chiba, 261-0024, Japan.
Iuchi T; Division of Neurological Surgery, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba, 260-8717, Japan.

Sci Rep ; 9(1): 17794, 2019 11 28.

Article in En | MEDLINE | ID: mdl-31780768

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Antineoplastic Agents, Alkylating / Positron-Emission Tomography / Temozolomide / Methionine Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2019 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google